Xolair Omalizumab - 150mg Vial for Subcutaneous Use
date: label: date made
content: ca 2013
label: product expiration date
content: 2016-08
name: label: maker
content: Genentech, Inc.
label: maker
content: Novartis Vaccines and Diagnostics Limited
notes: label: Description (Brief)
content: (From box)
label: Description (Brief)
content: For subcutaneous use
label: Description (Brief)
content: (From insert)
label: Description (Brief)
content: Xolair is indicated for:
label: Description (Brief)
content: -Moderate to severe persistent asthma in patients with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids.
label: Description (Brief)
content: Important Limitations of use:
label: Description (Brief)
content: -Not indicated for other allergic conditions
label: Description (Brief)
content: -Not indicated for acute bronchospasm or status asthmaticus
label: Description (Brief)
content: -Not indicated for pediatric patients less than 12 years of age
label: Location
content: Currently not on view
place: label: place made
content: United States: California, South San Francisco
label: place made
content: Switzerland
setName: label: See more items in
content: Medicine and Science: Medicine
label: See more items in
content: Health & Medicine
label: See more items in
content: The Antibody Initiative
label: See more items in
content: Antibody Initiative: Monoclonal Antibodies
creditLine: label: Credit Line
content: Gift of Genentech, Inc.
dataSource: label: Data Source
content: National Museum of American History
identifier: label: ID Number
content: 2013.0069.13
label: catalog number
content: 2013.0069.13
label: accession number
content: 2013.0069
objectType: label: Object Name
content: pharmaceutical
label: Object Name
content: biological
physicalDescription: label: Physical Description
content: glass (overall material)
label: Physical Description
content: metal (overall material)
label: Physical Description
content: plastic (overall material)
label: Physical Description
content: paper (overall material)
label: Physical Description
content: cardboard (overall material)
label: Physical Description
content: Omalizumab, 150mg (overall ingredient)
label: Measurements
content: overall: 1 in x 2 1/8 in x 3 3/8 in; 2.54 cm x 5.3975 cm x 8.5725 cm
label: Measurements
content: bottle of sterile water for injection: 2 3/16 in x 1 in; 5.55625 cm x 2.54 cm
label: Measurements
content: 10ml syringe: 1 7/8 in x 8 1/4 in x 3/4 in; 4.7625 cm x 20.955 cm x 1.905 cm
label: Measurements
content: alcohol wipe: 2 in x 2 in; 5.08 cm x 5.08 cm
label: Measurements
content: overall: 3 3/8 in x 2 in x 1 in; 8.5725 cm x 5.08 cm x 2.54 cm